Peripheral Interventions Market Size By Product (Catheters, Sheath, Stents {Bare-metal Stents, Drug-eluting Stents}, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters), By Application (Vascular Diseases {Peripheral Artery Disease, Venous Thrombosis, Atherosclerosis, Varicose Veins}, Cancer), By End-use (Hospitals, Catheterization Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Sep 2019  |  Report ID: GMI2915  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 180   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry trends

Peripheral Interventions Market size valued at USD 6.1 Billion in 2018 and is poised to witness growth of over 8.7% from 2019 to 2025.

Peripheral Interventions Market

Get more details on this report - Request Free Sample PDF

Peripheral interventions market includes devices used to diagnose and effectively treat various peripheral arterial and venous diseases, cancer and several other peripheral disorders. A wide range of products offered by key market players in the industry include balloon catheters, stents, atherectomy, thrombectomy, guide wires, microcatheters, and various other products. Over the years, peripheral vascular intervention has witnessed robust transformation in the diagnosis as well as treatment of various diseases and continues to foresee revolutionizing breakthroughs by prominent industry players.

The first coronary angioplasty combined with a drug delivery stent system was executed in 1999. Dr. Charles Theodore Dotter was the pioneer in modern medical technology with the discovery of catheter-delivery stent and angioplasty that was used to treat peripheral artery disease. New inventions and novel solutions for peripheral arterial occlusive disorder have provided significant advantages to vascular patients.

Peripheral Interventions Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 6.1 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 8.7% 2025 Value Projection: 10.5 Billion (USD)
Pages: 180 Tables, Charts & Figures: 305
Geographies covered (18): U.S., Canada, UK, Germany, France, Italy, Spain, Russia, China, India, Japan, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa
Segments covered: Product, Application, End-use and Region
Companies covered (14): Abbott Laboratories, AgioDynamics Inc., B. Braun, Boston Scientific Corporation, Biotronik, Cardinal Health, C.R. Bard (Becton Dickinson and Company), Cook Group, Depuy Synthes, Medtronic, Meril Life Sciences India Pvt Ltd., Teleflex, Terumo Interventional Systems and W.L. Gore & Associates
Growth Drivers:
  • Increasing prevalence of cardiovascular disorders
  • Rising adoption of non-invasive procedures
  • Technological advancements in peripheral intervention devices
  • Growing number of catheterization laboratories coupled with increasing number of healthcare professionals in emerging markets
Pitfalls & Challenges:
  • Lack of awareness regarding peripheral artery diseases
  • High set-up cost associated with peripheral intervention
  • Increasing risk of post-procedural complications

Request 15% Free Customization on this Report

Novel nanotechnology empowered devices will spur peripheral devices adoption rate

Continuous advances in peripheral tracking devices led to the development of new techniques and implementation of navigation-enabled ablation catheters over the recent years. For instance, Zilver PTX, the first drug-eluting and self-expanding peripheral stent launched by the Cook Medical Inc. was approved by the U.S. FDA in 2012. It was indicated for the treatment of lesions in native vascular disease of the knee arteries. Increasing geriatric population and health risks associated with sedentary lifestyle will boost the demand for peripheral vascular devices.

High cost of interventional devices will hinder the peripheral interventions market growth over the forecast years. Lack of awareness regarding peripheral artery diseases and delayed diagnosis will continue to limit the adoption rate of peripheral vascular devices.

Catheterization laboratories will foresee rise in peripheral intervention procedures

India Peripheral Interventions Market, By End-use, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF

Catheterization laboratories is estimated to expand at 8.6% CAGR from 2019 to 2025. With increase in prevalence of cardiovascular diseases, the awareness about health is growing, leading to the development of catheter lab facilities. In addition, increased preference for robotic-assisted surgeries is also anticipated to drive the segmental growth till 2025. However, complex and time-consuming transcatheter procedures and rising exposure of laboratory staff to harmful radiation during X-ray imaging may act as an obstacle to the segment growth.

Drug-eluting peripheral stents will emerge as the centerpiece for product innovation

Stents product segment in peripheral interventions market will witness over 8.5% CAGR owing to rising prevalence of arterial diseases coupled with innovations in stent systems. Drug-eluting stents is gaining popularity as they are coated with drugs that are released slowly to prevent the growth of scar tissues. For instance, Eluvia drug-eluting vascular stent system developed by Boston Scientific Inc., is rapidly being used for the overcoming challenges associated with restenosis. Thus, with enhanced procedural success rate and wide range of benefits, demand for drug-eluting stents is forecasted to rise over the projected years.

 More than 200 million patients with peripheral artery disease will drive the global peripheral interventions market growth

Peripheral artery disease (PAD) accounted for significant revenue share in 2018 and will continue to exhibit robust growth from 2019 to 2025. Rise in lifestyle associated diseases such as high blood pressure atherosclerosis, diabetes will boost the demand for vascular interventional applications in treating arteries of the lower extremities. According to the American Heart Association (AHA), approximately, 8.5 million people in the U.S. have PAD, with 20% accounted for by elderly population. With rising geriatric population, the incidence of chronic ischemia is increasing.

Increased governmental support and presence of advanced healthcare infrastructure will enhance device usage

Europe Peripheral Interventions Market, By End-use, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF

The U.S. peripheral interventions market will witness 8.5% CAGR over the foreseeable future. Growing adoption of non-invasive surgical procedures coupled with advanced medical treatment pattern will act as impact rendering factor for the market growth. According to the American College of Cardiology Foundation, more than 100,000 cardiac catheterization surgical procedures were conducted in 2014. Growing number of peripheral vascular patients will lead to constant enhancement in the monitoring and diagnostic technology. Recently, the U.S star-up, Proximo Medical, strategically collaborated with Biotronik for expansion of peripheral vascular intervention product line in the U.S market. Such inorganic growth strategies adopted by market players will boost the overall market size of peripheral vascular devices in the upcoming years.

Indian Market is projected to witness robust growth over the estimated timeframe. Increasing number of hospitals and government expenditure will serve to be a high impacting factor for the market growth. Additionally, a large number of developing cities are establishing catheter laboratories, thereby augmenting the healthcare infrastructure. Implementation of several initiatives organized by government & private organizations will increase awareness about peripheral vascular diseases, thus driving demand for peripheral interventions devices.

 Boston Scientific Corporation is leading the peripheral interventions market owing to continuous innovations

Few of the notable players operating in the peripheral interventions market are Abbott Vascular Devices, AgioDynamics Inc., B. Braun, Boston Scientific Corporation, Cardinal Health, C.R. Bard (Becton Dickinson and Company) and Medtronic, among others. Top players are implementing numerous strategies such as new product launches, acquisitions and collaborations, in order to capture high revenue share in peripheral interventions business.

Some of the recent industry developments:

  • In August 2019, Boston Scientific announced the acquisition of BTG plc., a company that develops and commercializes products used in minimally invasive procedures used for cancer and vascular disorders. This alliance will aid in expanding Boston Scientific’s interventional and vascular product portfolio.
  • In April 2019, Biotronik launched its new product, named, ‘Carnelian Support Catheter’. Carnelian Support is specifically designed for the support and exchange of guidewires into peripheral vasculature. This launch will help the company to expand its product portfolio in peripheral division and aid in treating complex lesions.

The peripheral interventions market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

By Product

  • Catheters
  • Sheath
  • Stents
    • Bare metal stents
    • Drug-eluting stents
    • Others
  • Guide wires
  • Atherectomy devices
  • Embolic devices
  • Thrombectomy devices
  • IVC filters
  • Others

By Application

  • Peripheral vascular diseases
    • Peripheral artery disease
    • Venous thrombosis
    • Atherosclerosis
    • Varicose veins
    • Others
  • Cancer
  • Others

By End-use

  • Catheterization laboratories
  • Hospitals
  • Ambulatory surgical centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X